Mural Health Technologies provides a clinical trial participant management platform centered on its Mural Link software. Mural Link delivers next-generation payment technology integrated with transportation, communication, and data-collection functionalities. The company plans to use proceeds from a recent $8M seed raise to expand its platform and modernize the clinical trial participant experience. Founded in 2022 by Sam Whitaker, Jason Dong, and Shawn Milochik and based in Berwyn, PA, Mural Health already counts three of the top 15 pharmaceutical companies, several biotechs including Sonex Health, and research sites as customers. It has partnered with eClinical platforms such as Clinical Ink and Ledger Run to offer an integrated solution. The seed investors include Bessemer Venture Partners, Virtue VC, Operator Partners, Arkitect Ventures, Correlation Ventures, and Project Mayhem Ventures.

Total raised

$8M

Funding rounds

1

Latest round

Seed

Latest activity

Sep 2023